Insider · CIK 0001843594
James Peyer
Files at FTH (Sensei Biotherapeutics, Inc.). First filing Dec 8, 2025, latest Jun 1, 2026.
In brief
James Peyer files SEC Form 4 as director and 10% owner at FTH (Sensei Biotherapeutics, Inc.). Since Dec 8, 2025, James Peyer has reported 0 open-market buys worth $0 and 3 open-market sells worth $788k, the latest filed on Jun 1, 2026.
A track record needs three past buys with six months of prices behind them; James Peyer has 0, so none is measured yet.
The newest scored trade: sold $501k of FTH on Jun 1, 2026, filed Jun 1, 2026, scored 43 (moderate). In the last 12 months: 0 buys worth $0 and 3 sells worth $788k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
FTH: Sensei Biotherapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 43Moderate | Sensei Biotherapeutics, Inc. | $501k 25,000 shares | -16% | +230% from low-44% from high | |
| 12Weak | Sensei Biotherapeutics, Inc. | $55k 6,612 shares | -4% | - | |
| 38Weak | Sensei Biotherapeutics, Inc. | $233k 21,295 shares | -12% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Feb 18, 2026 | FTH Sensei Biotherapeutics, Inc. | 950 0.08% of outstanding | $26k | Feb 18, 2026 | $6,707 |
| Dec 9, 2025 | FTH Sensei Biotherapeutics, Inc. | 841 0.07% of outstanding | $6,707 | Dec 9, 2025 | $260k |
Transactions
Every row this insider has filed, 13 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | FTH Sensei Biotherapeutics, Inc. | SOpen-market sale Common Stock | -24,524 | $20.00 | $490k | 130,618 | Jun 1, 2026 |
| Jun 1, 2026 | FTH Sensei Biotherapeutics, Inc. | SOpen-market sale Common Stock | -476 | $21.14 | $10k | 130,142 | Jun 1, 2026 |
| Dec 8, 2025 | FTH Sensei Biotherapeutics, Inc. | SOpen-market sale Common Stockindirect: See footnote | -3,105 | $8.59 | $27k | 158,254 | Dec 10, 2025 |
| Dec 9, 2025 | FTH Sensei Biotherapeutics, Inc. | SOpen-market sale Common Stockindirect: See footnote | -2,666 | $7.95 | $21k | 155,588 | Dec 10, 2025 |
| Dec 9, 2025 | FTH Sensei Biotherapeutics, Inc. | MOption exercise Common Stockindirect: See footnote | +395 | $6.40 | $2,528 | 155,983 | Dec 10, 2025 |
| Dec 9, 2025 | FTH Sensei Biotherapeutics, Inc. | SOpen-market sale Common Stockindirect: See footnote | -395 | $8.04 | $3,176 | 155,588 | Dec 10, 2025 |
| Dec 9, 2025 | FTH Sensei Biotherapeutics, Inc. | SOpen-market sale Common Stockindirect: See footnote | -446 | $7.92 | $3,532 | 155,142 | Dec 10, 2025 |
| Dec 9, 2025 | FTH Sensei Biotherapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative | -395 | $0.00 | $0 | 0 | Dec 10, 2025 |
| Dec 4, 2025 | FTH Sensei Biotherapeutics, Inc. | SOpen-market sale Common Stockindirect: See footnote | -5,000 | $9.06 | $45k | 177,654 | Dec 8, 2025 |
| Dec 5, 2025 | FTH Sensei Biotherapeutics, Inc. | SOpen-market sale Common Stockindirect: See footnote | -14,508 | $11.40 | $165k | 163,146 | Dec 8, 2025 |
| Dec 5, 2025 | FTH Sensei Biotherapeutics, Inc. | SOpen-market sale Common Stockindirect: See footnote | -1,745 | $12.29 | $21k | 161,401 | Dec 8, 2025 |
| Dec 5, 2025 | FTH Sensei Biotherapeutics, Inc. | SOpen-market sale Common Stockindirect: See footnote | -42 | $13.16 | $553 | 161,359 | Dec 8, 2025 |
| May 21, 2025 | FTH Sensei Biotherapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivativeindirect: See footnote | +19,000 | $0.00 | $0 | 19,000 | May 23, 2025 |
Questions about James Peyer
Answered from the filings on this page, as of the latest one.
Is James Peyer buying or selling?
In the last 12 months James Peyer reported 0 open-market buys worth $0 and 3 open-market sells worth $788k on SEC Form 4; the latest was sold $501k of FTH on Jun 1, 2026. Grants, option exercises and tax withholding are not counted.
How did James Peyer's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and James Peyer has 0.
Where does James Peyer file Form 4?
James Peyer has filed Form 4 at FTH (Sensei Biotherapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.